|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-3-30
|
|
pubmed:abstractText |
Dystroglycan (DG) is a non-integrin adhesion molecule connecting the extracellular matrix to the actin cytoskeleton. Decreased expression of DG has been reported in several human cancers and related to tumour aggressiveness.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1465-3931
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-54
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20350218-Carcinoma, Squamous Cell,
pubmed-meshheading:20350218-Dystroglycans,
pubmed-meshheading:20350218-Female,
pubmed-meshheading:20350218-Humans,
pubmed-meshheading:20350218-Immunohistochemistry,
pubmed-meshheading:20350218-Kaplan-Meier Estimate,
pubmed-meshheading:20350218-Male,
pubmed-meshheading:20350218-Middle Aged,
pubmed-meshheading:20350218-Mouth Neoplasms,
pubmed-meshheading:20350218-Neoplasm Staging,
pubmed-meshheading:20350218-Prognosis,
pubmed-meshheading:20350218-Tumor Markers, Biological
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Expression of alpha-dystroglycan correlates with tumour grade and predicts survival in oral squamous cell carcinoma.
|
|
pubmed:affiliation |
Centro di Ricerche Oncologiche Giovanni XXIII-Istituto di Patologia Generale, Università Cattolica del Sacro Cuore, Rome.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
